Nordson (NDSN) PT Raised to $287 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Nordson Corporation Reports Third Quarter Fiscal 2024 Results and Updates Annual Guidance
August 21, 2024 4:30 PM EDTThird Quarter Highlights:
Sales were $662 million, an increase of 2% year-over-year and in-line with mid-point of guidance Earnings per diluted share were $2.04 Adjusted earnings per diluted share were $2.41, $0.08 above the mid-point of guidanceUpdated Full-Year Guidance:
Increasing full fiscal year 2024 revenue guidance to reflect the addition of Atrion acquisition Maintaining full fiscal year 2024 adjusted earnings per diluted share guidance, inclusive of the slightly dilutive fourth quarter Atrion acquisition impactWESTLAKE,... More
Nordson Corporation Completes Acquisition of Atrion Corporation
August 21, 2024 8:35 AM EDTWESTLAKE, Ohio--(BUSINESS WIRE)-- Nordson Corporation (Nasdaq: NDSN) (the Company or Nordson) has completed the acquisition of Atrion Corporation (Atrion), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions. The completion of the transaction follows the Companys May 28, 2024 announcement that it had entered into an agreement to acquire the business. This acquisition will expand Nordsons medical... More
